CATALAYER NEWS
FDA Alignment to Advance ProstACT Global Phase 3 Trial – Company Announcement - Financial Times
Source: Financial Times · 2026-07-01
Full article text is available in the Catalayer news terminal.
MORE FROM FINANCIAL TIMES
Anthropic releases cheaper AI model ahead of IPO - Financial Times
2026-09-22
Trump threatens to ‘annihilate’ Iran in combative UN speech - Financial Times
2026-09-22
BlackRock American Income Trust Plc - Issue of Equity – Company Announcement - Financial Times
2026-09-22
Fidelity European Trust Plc - Transaction in Own Shares – Company Announcement - Financial Times
2026-09-22
Strategic Equity Capital Plc - Transaction in Own Shares – Company Announcement - Financial Times
2026-09-22
RELATED ON CATALAYER
Related Topics
Biotech & FDA NewsRELATED MARKETS
Prediction Markets